MESSAGE FROM THE PRESDENT
Jeffrey S.Heier, MD
Dear NEOS Members,
Our June 2nd meeting marks the final meeting of another stellar academic year. With your support, we have enjoyed valuable programs ranging from advances in anterior segment surgical techniques to imaging both the front and back of the eye; from complications of cataract surgery to controversies in our daily practices. With your support, we have continued to experience outstanding lecturers from across the country and from our own New England states. With your support, we have continued to benefit from lively discussions in program panels, at luncheon seminars, and in subspecialty sessions; discussions that help to guide our outstanding care of patients. The common factor, and the key element to NEOS’ continued success, is your support! The Executive Committee is truly grateful and fully appreciative of this support, and recognizes it comes in many forms. It comes in the form of dedication to the important committees that many of you have joined; it comes in the support to the Educational Endowment Fund to which many of you have contributed; and most important, it comes in your support to the NEOS programs, as presenters, as moderators, and as an engaged audience.
As yet another example of our members’ commitment to education and collegiality, the support of our 1st NEOS Grand Rounds at the April meeting was outstanding, with a standing room only crowd, excellent presentations, and lively discussion. It is clear that NEOS members crave both the opportunity to learn as well as the environment to enjoy the camaraderie of their New England colleagues. We thank the Young Ophthalmologists Committee for sponsoring the 1st and 2nd Grand Rounds, and look forward to these continuing next year.
Finally, I would like to sincerely thank the Executive Committee for their support, the committees for their dedication and insight, Michael Bradbury for his guidance, Judy Cerone Keenan for her tireless efforts, and my family for their love and support and for allowing me the time to serve the Society. Most importantly, I would like to thank the membership for the opportunity of serving as NEOS President; it has truly been a privilege and an honor!
Guest of Honor:
David S. Greenfield, MD
David S. Greenfield, MD is Professor of Ophthalmology and serves as the Douglas R. Anderson Distinguished Chair in Ophthalmology, Vice Chair of Academic Affairs of the Department of Ophthalmology, Co-Director of the Glaucoma Service, and Director of the Glaucoma Fellowship Program at the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL. He earned his medical degree from the New York University School of Medicine in 1990 and completed his residency at the New England Eye Center, Tufts University School of Medicine, Boston, in 1994. Dr. Greenfield completed a 1994-5 Heed Fellowship in Glaucoma and a 1995 Heed-Knapp Fellowship in Neuro-Ophthalmology at the Bascom Palmer Eye Institute, University of Miami School of Medicine. He previously joined The New York Eye & Ear Infirmary in 1996 as Clinical Assistant Professor of Ophthalmology and Neurology.
Dr. Greenfield is a clinician, surgeon, and scientist, and has held prestigious leadership positions throughout Ophthalmology. Dr. Greenfield is the immediate Past President of the American Glaucoma Society and the American Glaucoma Society Foundation (2014-16). He is the co-founder of the International Society for Imaging in the Eye (ISIE) and served as Secretary-Treasurer from 2002 – 2007, and is the Executive Vice President and co-founder of The Florida Glaucoma Society. Dr. Greenfield serves as the Executive Editor of American Journal of Ophthalmology, is a member of the editorial boards of Journal of Glaucoma and International Glaucoma Review, and has served as the Associate Editor of Ophthalmic Surgery Lasers and Imaging (2002-2013). Dr. Greenfield has served as past Chair of the AGS Scientific Program Committee, Bylaws and Strategic Planning Committees, and member of the AAO Glaucoma Subspecialty Day Committee, Technology Assessment Committee, and EyeCare America Glaucoma Education Committee. Dr. Greenfield has served as Co-Chair of the Glaucoma Subspecialty Day of the American Academy of Ophthalmology (2003-4), and was awarded the 2010 AGS Clinician-Scientist Lectureship, 2011 American Academy of Ophthalmology Senior Achievement Award, 2015 American Academy of Ophthalmology Robert N. Shaffer Lectureship, and 2016 AAO Secretariat Award.
Dr. Greenfield has taught and published extensively in all aspects of glaucoma diagnosis, monitoring, and therapy. His research interests include optic disc and retinal nerve fiber imaging, reflectance properties of the retinal nerve fiber layer, normal-tension glaucoma, bleb-related ocular infection, and complex glaucoma filtration surgery. He was the recipient of a National Eye Institute consortium grant studying advanced imaging technology in glaucoma, and received continuous funding from the NIH from 1999-2013. He has delivered numerous guest lectures and named lectures nationally and internationally, and has published over 300 original scientific papers, abstracts and book chapters. He has trained numerous clinical and research fellows, many of whom hold distinguished academic positions worldwide.
Janey Wiggs, MD, PhD
Janey L. Wiggs, M.D., Ph.D. is a physician scientist at the Massachusetts Eye and Ear Infirmary and Harvard Medical School. She is currently the Paul Austin Chandler Professor of Ophthalmology at Harvard Medical School and is the Vice Chair for Clinical Research in Ophthalmology at the Massachusetts Eye and Ear Infirmary. She also directs the CLIA-certified genetic testing laboratory at the Massachusetts Eye and Ear Infirmary and is a co-director of the Ocular Genomics Institute.
Dr. Wiggs received her B.A. and Ph.D. degrees in biochemistry from the University of California at Berkeley and her M.D. degree from Harvard Medical School. She did post-doctoral training in molecular genetics under the direction of Dr. Ted Dryja. Dr. Wiggs completed the ophthalmology residency at the Massachusetts Eye and Ear Infirmary and received fellowship training in glaucoma and also in medical genetics and is certified by the both the American Board of Ophthalmology and the American Board of Medical Genetics. Dr. Wiggs’ research program is focused on the discovery and characterization of genetic factors that contribute to the blinding eye disease glaucoma and is funded by the National Eye Institute (NEI) as well as other nonprofit foundations. She is the co-chair of the US-INDO joint working group (NEI) and is a member of the NEI eyeGENE consortium.
Dr. Wiggs was the inaugural chair of the Genetics Group for ARVO and is an ARVO gold fellow. She currently serves on the editorial boards of IOVS, JAMA Ophthalmology, Molecular Vision, Journal of Glaucoma, and Annual Reviews in Vision Science. She is a member of the scientific advisory boards for the Glaucoma Research Foundation, the Glaucoma Foundation and Research to Prevent Blindness and is a past member of the National Advisory Council of the National Eye Institute. She has received the Heed Award, the Heed/Knapp Award, the Research to Prevent Blindness Scholar Award, the AAO Honor Award, the Lew Wasserman Merit Award, the Alcon Research Award and was a winner of the NEI Audacious Goal competition. She is a member of the Glaucoma Research Society, the American Ophthalmological Society, and the Academia Ophthalmologica Internationalis.
Dr. Wiggs' principal clinical and research interests are inherited diseases of the eye, particularly glaucoma and optic neuropathies. She is investigating the genetic etiologies of both early-onset and adult forms of glaucoma and is the PI of the NEIGHBORHOOD consortium for gene discovery in primary open angle glaucoma.